Currently out of the existing stock ratings of David Maris, 55 are a BUY (50.93%), 44 are a HOLD (40.74%), 9 are a SELL (8.33%).

David Maris

Work Performance Price Targets & Ratings Chart

Analyst David Maris, currently employed carries an average stock price target met ratio of 50.61% that have a potential upside of 19.46% achieved within 238 days. Previously, David Maris worked at WELLS FARGO.

David Maris’s has documented 211 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 28-Oct-2021.

Wall Street Analyst David Maris

Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for MNK (MALLINCKRODT PLC) at 11/8/2017. The price target of $22 was fulfilled within 1 day with a profit of $2.02 (10.11%) receiving and performance score of 101.1.

Average potential price target upside

of $51.87 (36.79%) on AGN (ALLERGAN PLC).
of $33.23 (24.8%) on JAZZ (JAZZ PHARMACEUTICALS PLC).
of $14.78 (62.04%) on BHC (BAUSCH HEALTH COMPANIES).

AGN Allergan plc EBS Emergent Biosolutions MNK Mallinckrodt plc MYL Viatris PRGO Perrigo Company PLC TEVA Teva Pharma Industries Ltd ADR BHC Bausch Health Companies JAZZ Jazz Pharmaceuticals PLC FLXN Flexion Therapeutics IRWD Ironwood Pharmaceuticals NEOS Neos Therapeutics VTRS Viatris AMPH Amphastar P MDWD Mediwound Ltd SIEN Sientra

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Gregg Gilbert (BAML)